» Authors » Lauren Griffin

Lauren Griffin

Explore the profile of Lauren Griffin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 136
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kushwaha S, Jawahar V, Kumar A, Griffin L, Rothstein T, Sehgal D, et al.
J Immunol Methods . 2025 Feb; 538:113823. PMID: 39892828
Human monoclonal antibodies (mAbs) are an important segment in precision therapeutics. Various methodologies are available for generating them. Recombinant human mAbs expression from sorted single B cells is preferred for...
2.
Griffin L, Garren M, Maffe P, Ghalei S, Brisbois E, Handa H
ACS Appl Bio Mater . 2024 Apr; 7(5):3086-3095. PMID: 38652779
Of the 27 million surgeries performed in the United States each year, a reported 2.6% result in a surgical site infection (SSI), and species are commonly the culprit. Alternative therapies,...
3.
Carrara M, Kelly M, Griffin L, Margout-Jantac D
Phytochem Anal . 2023 Nov; 35(3):476-482. PMID: 37984858
Introduction: Olive leaves, abundant by-products of the olive oil industry, are a rich source of oleuropein, an important polyphenol in olive leaves. So far, no published methods have been validated...
4.
Chug M, Griffin L, Garren M, Tharp E, Nguyen G, Handa H, et al.
Biomater Sci . 2023 Aug; 11(19):6561-6572. PMID: 37594048
Antibiotic lock therapy (ALT) is standard clinical practice for treating bacteremia linked with catheter-related bloodstream infections (CRBSIs). However, this strategy frequently fails against multi-drug-resistant bacteria in clinical settings. In this...
5.
Estes Bright L, Griffin L, Mondal A, Hopkins S, Ozkan E, Handa H
J Colloid Interface Sci . 2022 Aug; 628(Pt B):911-921. PMID: 36030716
Hypothesis: Alginate is widely used in biomedical applications due to its high biocompatibility as well as structural and mechanical similarities to human tissue. Further, simple ionic crosslinking of alginate allows...
6.
Griffin L, Douglass M, Goudie M, Hopkins S, Schmiedt C, Handa H
ACS Appl Mater Interfaces . 2022 Feb; 14(9):11116-11123. PMID: 35225600
Blood-contacting medical devices (BCMDs) are inevitably challenged by thrombi formation, leading to occlusion of flow and device failure. Ideal BCMDs seek to mimic the intrinsic antithrombotic properties of the human...
7.
Garren M, Maffe P, Melvin A, Griffin L, Wilson S, Douglass M, et al.
ACS Appl Mater Interfaces . 2021 Nov; 13(48):56931-56943. PMID: 34818503
It has been previously demonstrated that metal nanoparticles embedded into polymeric materials doped with nitric oxide (NO) donor compounds can accelerate the release rate of NO for therapeutic applications. Despite...
8.
Nargis N, Li Q, Griffin L, Asare S, Bandi P, Majmundar A, et al.
J Occup Health . 2021 Oct; 63(1):e12283. PMID: 34599638
Introduction: The COVID-19 pandemic has led to a major shift in workspace from office to home. This report examined how telecommuting is related to smoking behavior of wage and salary...
9.
Mondal A, Singha P, Douglass M, Estes L, Garren M, Griffin L, et al.
ACS Appl Mater Interfaces . 2021 Sep; 13(37):43892-43903. PMID: 34516076
Despite technological advancement, nosocomial infections are prevalent due to the rise of antibiotic resistance. A combinatorial approach with multimechanistic antibacterial activity is desired for an effective antibacterial medical device surface...
10.
Zalake M, Tavasolli F, Griffin L, Krieger J, Lok B
Intell Virtual Agents . 2021 May; 15(2):147-162. PMID: 34027518
To influence user behaviors, Internet-based virtual humans (VH) have been used to deliver health interventions. However, Internet-based VH health interventions face challenges. The challenges can affect user perceptions of an...